Received FDA clearance of Investigational New Drug application (IND) for PRT12396, mutant-selective JAK2V617F inhibitor in the first quarter of ...

Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2025 Earnings Call Transcript March 26, 2026 Lucid Diagnostics Inc. misses on earnings expectations. Reported EPS is $-0.1 EPS, expectations were $-0.07.

Quarter Performance Driven by Strength in Acthar® Gel1 and XIAFLEX®2Financial and Operational Performance Exceeded Expectations as Company ...

Detailed price information for Apellis Pharmaceuticals Inc (APLS-Q) from The Globe and Mail including charting and trades.

Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy.

Xtant Medical Holdings, Inc. (AMEX:XTNT) Q4 2025 Earnings Call Transcript March 31, 2026 Xtant Medical Holdings, Inc. beats ...

With the help of artificial intelligence, a coalition of Bay Area institutions identified 18 FDA-approved drugs that could improve the lives of those suffering from amyotrophic lateral sclerosis, ...

Starting April 1, 2026, the agency will accept only this version and will reject older editions received on or after that date. Forms using the prior 01/20/25 edition remain valid only if they arrive ...

TUCSON, Ariz., March 12, 2026 (GLOBE NEWSWIRE)-- Picard Medical, Inc. (NYSE American: PMI) (the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart ...

PUTRAJAYA: Health Minister Datuk Seri Dr Dzulkefly Ahmad said the ministry will investigate allegations that some foreign patients have violated administrative procedures to avoid paying hospital ...

Members of the Jewish community are failing to tick 'kosher' on dietary requirement forms over fears of racism by NHS staff - as Wes Streeting vowed to sack those who act in such a manner. Speaking ...